Fig. 2
From: Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis
Effectiveness of regionally-specific immunotherapy by duration of treatment in 97 atopic dogs. Dogs with follow-up examinations beyond 21 months (2 classified as excellent, 2 as good, and 2 as fair) are not depicted